GO
Loading...

Enter multiple symbols separated by commas

Mergers and Acquisitions Takeover Bids

More

  • Hillshire responds to Pilgrim's Pride takeover offer Tuesday, 27 May 2014 | 11:26 AM ET
    Hillshire responds to Pilgrim's Pride takeover offer

    CNBC's Dominic Chu reports Hillshire Brands has responded to the proposal by Pilgrim's Pride to acquire Hillshire for about $6.4 billion

  • Hillshire gets takeover offer from Pilgrim's Pride Tuesday, 27 May 2014 | 9:05 AM ET
    Hillshire gets takeover offer from Pilgrim's Pride

    The "Squawk on the Street" news team discusses the report that Pilgrim's Pride is offering to acquire Hillshire Brands for $6.4 billion.

  • Cramer eyes food fight Tuesday, 27 May 2014 | 8:53 AM ET
    Cramer eyes food fight

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today Cramer shares his thoughts on Pilgrim Pride's bid for Hillshire Brands.

  • Plotting Pfizer's next move Tuesday, 27 May 2014 | 6:20 AM ET
    Pfizer drops bid for AstraZeneca

    John Eade, Argus Research, discusses Pfizer's likely next move after abandoning its attempt to buy AstraZeneca. There's a good chance AstraZeneca management could ask Pfizer to come back to the table, says Eade.

  • Pfizer's final bid rejected Monday, 19 May 2014 | 2:17 PM ET
    Pfizer's final bid rejected

    $117 billion was not enough for AstraZeneca. CNBC's Meg Tirrell looks at Pfizer and AstraZeneca's stocks.

  • Next big takeover Monday, 19 May 2014 | 2:12 PM ET
    Next big takeover

    CNBC's Herb Greenberg plays a game of "deal or no deal" and rounds up potential next takeover targets.

  • Faber Report: Hillshire to acquire Pinnacle Monday, 12 May 2014 | 10:16 AM ET
    Faber Report: Hillshire to acquire Pinnacle

    CNBC's David Faber reports Hillshire Brands is buying Pinnacle Foods. And Faber comments on Allergan's rejection of Valeant's takeover bid.

  • What Cramer expects from IPO market Monday, 12 May 2014 | 9:08 AM ET
    What Cramer expects from IPO market

    Allergan has rejected a $47 billion takeover bid by Valeant Pharmaceuticals. The "Squawk on the Street" news team discuss m&a in pharmaceuticals and the IPO market.

  • Ackman: Makes sense to be partners with Icahn instead of enemies

    Bill Ackman, Pershing Square Capital Management, explains what led him to reach out to activist investor Carl Icahn. Ackman calls him "a charming guy."

  • Ackman: Allergan, Valeant merger economically right thing to do

    Bill Ackman, Pershing Square Capital Management, weighs in on the Valeant and Allergan controversy and long-term shareholder activism.

  • Ackman: No alternative to Fannie and Freddie Monday, 5 May 2014 | 4:01 PM ET
    Ackman: No alternative to Fannie and Freddie

    CNBC's Scott Wapner speaks to Bill Ackman, Pershing Square Capital Management, about the "winding down" of the old version of Fannie and Freddie and discusses the importance of reform to their programs.

  • AstraZeneca rejects new Pfizer bid Friday, 2 May 2014 | 9:07 AM ET
    AstraZeneca rejects new Pfizer bid

    AstraZeneca has rejected Pfizer's sweetened bid claiming it undervalues the company. The "Squawk on the Street" news team shares their thoughts on the latest bid and the U.S. tax code.

  • Pfizer prepares sweeter bid for AstraZeneca Thursday, 1 May 2014 | 2:49 PM ET

    Pfizer CEO Ian Read recently met with U.K.-based investors to discuss a second bid for AstraZeneca, valuing the firm at $106 billion, sources said.

  • GE's Immelt: Alstom deal will be executed Wednesday, 30 Apr 2014 | 1:19 PM ET
    GE's Immelt: Alstom deal will be executed

    Alstom has until June 2 to review General Electric's $13.5 billion bid for its energy assets, reports CNBC's Mary Thompson.

  • GE's big bid for Alstom Wednesday, 30 Apr 2014 | 10:47 AM ET
    GE's big bid for Alstom

    Alstom is accepting GE's $13.5 billion bid for its energy assets, reports CNBC's Mary Thompson.

  • GE CEO confident Alstrom deal will go through Wednesday, 30 Apr 2014 | 9:36 AM ET
    GE CEO confident Alstrom deal will go through

    Jeffrey Immelt, General Electric chairman & CEO, discusses how the synergies between GE and Alstrom will likely drive earnings and increase the company's industrial mix.

  • Alstom backs GE bid but Siemens sweetens deal Wednesday, 30 Apr 2014 | 7:02 AM ET
    Alstom backs GE bid but Siemens sweetens deal

    CNBC's Mary Thompson reports the latest details on General Electric's attempt to acquire French company Alstom.

  • Alstrom bidding war standoff: GE vs. SI Wednesday, 30 Apr 2014 | 6:07 AM ET
    Alstrom bidding war standoff: GE vs. SI

    Nicholas Heymann, William Blair analyst, discusses General Electric's attempt to acquire Alstrom but Germany's Siemens AG is not giving up its pursuit either. Currently GE has the green light from Alstrom shareholders, says Heymann.

  • Siemens will make Alstom offer: Report Tuesday, 29 Apr 2014 | 11:11 AM ET
    Siemens will make Alstom offer: Report

    CNBC's David Faber reports Siemens will make an offer for Alstonm.

  • Pfizer engaging in legal tax avoidance: Bernstein Monday, 28 Apr 2014 | 3:21 PM ET
    Pfizer engaging in legal tax avoidance: Bernstein

    Jared Bernstein, senior fellow at The Center on Budget and Policy Priorities, and Rep. Todd Young, R-Ind., discusses how America's broken corporate tax code can cause companies, like Pfizer, to incorporate outside the U.S.